Valuation: LifeMD, Inc.

Market Cap 132M 117M 110M 99.83M 188M 12.7B 190M 1.33B 514M 6.49B 496M 485M 20.83B P/E 2026 *
-5.28x
P/E 2027 * -30x
Enterprise Value 132M 117M 110M 99.83M 188M 12.7B 190M 1.33B 514M 6.49B 496M 485M 20.83B EV / Sales 2026 *
0.64x
EV / Sales 2027 * 0.54x
Free-Float
84.02%
Yield 2026 *
-
Yield 2027 * -
1 day-3.86%
1 week-7.74%
Current month-5.52%
1 month-10.75%
3 months-43.74%
6 months-21.94%
Current year-19.65%
1 week 2.72
Extreme 2.725
3.04
1 month 2.72
Extreme 2.725
3.5
Current year 2.56
Extreme 2.56
5.38
1 year 2.56
Extreme 2.56
7.12
3 years 2.56
Extreme 2.56
15.84
5 years 1.14
Extreme 1.14
15.84
10 years 0.42
Extreme 0.421
33.02
Manager TitleAgeSince
Chief Executive Officer 39 2025-07-31
Director of Finance/CFO 57 2026-03-15
Chief Tech/Sci/R&D Officer - 2026-05-31
Director TitleAgeSince
Chairman 65 -
Director/Board Member 75 2014-09-03
Chairman 43 2019-06-10
Date Insider Type Main position Quantity % Market Cap. Importance
8/11/26 Free

Director

35,000 0.0724%
8/11/26 Free

Director

35,000 0.0724%
8/11/26 Free

Director

35,000 0.0724%
Change 5-day change 1-year change 3-year change Capi.($)
-3.86%-7.74%-60.40%-56.23% 132M
+0.35%-2.99%+24.73%+32.07% 242B
+1.09%-4.65%+1.77%+0.15% 150B
-2.32%-3.27%-11.53%+32.87% 138B
-1.46%-3.01%-55.73%-19.33% 61.74B
-0.05%-1.32%+11.09%+23.08% 49.08B
+0.66%+0.19%-19.29%-21.24% 47.43B
+0.66%-2.90%+20.97%+51.29% 47.3B
-3.05%-2.62%-9.13%+35.86% 44.25B
-0.08%-1.92%+32.09%+57.18% 41.78B
Average -0.54%-3.03%-6.54%+13.57% 82.28B
Weighted average by Cap. +0.15%-3.27%+3.36%+21.47%

Financials

2026 *2027 *
Net sales 208M 184M 172M 157M 296M 19.96B 299M 2.08B 808M 10.2B 780M 763M 32.75B 245M 218M 203M 185M 350M 23.57B 353M 2.46B 954M 12.05B 921M 901M 38.68B
Net income -24.81M -22.04M -20.57M -18.75M -35.36M -2.38B -35.69M -249M -96.46M -1.22B -93.13M -91.11M -3.91B -4.54M -4.04M -3.77M -3.44M -6.48M -437M -6.54M -45.61M -17.67M -223M -17.06M -16.69M -717M
Net Debt - -
Logo LifeMD, Inc.
LifeMD, Inc. is a patient-centric, direct-to-patient healthcare company. The Company is engaged in providing patients access to virtual medical care and pharmacy services. Its telehealth platform helps patients access licensed providers for diagnoses, virtual care, and prescription medications, often delivered on a recurring basis and sells over the counter (OTC) products. Its products are available on a subscription or membership basis, where a patient can subscribe to receive regular shipments of prescribed medications or products. The Company's men's brand, RexMD, offers access to virtual medical treatment for a variety of men's health needs, including erectile dysfunction, premature ejaculation and hair loss. Its vertically integrated care model combines technology, affiliated clinical services, pharmacy infrastructure, and artificial intelligence (AI)-enabled operational systems to deliver longitudinal care.
Employees
350
Date Price Change Volume
26-10-02 $2.740 -3.86% 709,134
26-10-01 $2.850 -1.72% 712,010
26-09-30 $2.900 +0.69% 725,486
26-09-29 $2.880 -1.71% 809,504
26-09-28 $2.930 -1.35% 602,524
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
2.740USD
Average target price
8.125USD
Spread / Average Target
+196.53%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. LFMD Stock